MCYSX
Price
$13.14
Change
+$0.05 (+0.38%)
Updated
Sep 17 closing price
Net Assets
118.04M
RNWAX
Price
$90.32
Change
+$0.03 (+0.03%)
Updated
Sep 17 closing price
Net Assets
74.08B
Interact to see
Advertisement

MCYSX vs RNWAX

Header iconMCYSX vs RNWAX Comparison
Open Charts MCYSX vs RNWAXBanner chart's image
NYLI Candriam Emerging Markets Eq Cl R6
Price$13.14
Change+$0.05 (+0.38%)
VolumeN/A
Net Assets118.04M
American Funds New World R1
Price$90.32
Change+$0.03 (+0.03%)
VolumeN/A
Net Assets74.08B
MCYSX vs RNWAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MCYSX vs. RNWAX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCYSX is a Buy and RNWAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 74.1B vs. MCYSX (118M). MCYSX pays higher dividends than RNWAX: MCYSX (0.60) vs RNWAX (0.00). MCYSX was incepted earlier than RNWAX: MCYSX (8 years) vs RNWAX (23 years). RNWAX (1.66) is less costly to investors than MCYSX (1.25). MCYSX is a more actively managed with annual turnover of: 101.00 vs. RNWAX (37.00). MCYSX has a lower initial minimum investment than RNWAX: MCYSX (0) vs RNWAX (250). MCYSX annual gain was more profitable for investors over the last year : 29.34 vs. RNWAX (15.82). MCYSX return over 5 years is better than : 28.57 vs. RNWAX (26.96).
MCYSXRNWAXMCYSX / RNWAX
Total Expense Ratio1.011.6661%
Annual Report Gross Expense Ratio1.251.6675%
Fund Existence8 years23 years-
Gain YTD27.69722.667122%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets118M74.1B0%
Annual Yield % from dividends0.600.00-
Returns for 1 year29.3415.82185%
Returns for 3 years51.0446.83109%
Returns for 5 years28.5726.96106%
Returns for 10 yearsN/A89.58-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNTH38.841.37
+3.66%
Dianthus Therapeutics
FERAU10.50N/A
N/A
Fifth Era Acquisition Corp I
SIMA10.46N/A
N/A
SIM Acquisition Corp I
STVN26.93-0.30
-1.10%
Stevanato Group SpA
CPIX3.23-0.13
-3.87%
Cumberland Pharmaceuticals